KM Research Hub
← 返回论文库
已完成 入排:符合 图源:可得 入排置信度 0.98

Long-term outcomes by lobular vs ductal histology in 4 National Surgical Adjuvant Breast and Bowel Project adjuvant breast cancer trials.

Julia Foldi, Neil Carleton, Stewart J Anderson, Priya Rastogi, Adrian Lee, Marija Balic, Charles E Geyer, Steffi Oesterreich, Norman Wolmark

J Natl Cancer Inst 117(1) 163-168

PMID39128018
PMCIDPMC11717417
DOI10.1093/jnci/djae188
发表日期2024-08-11
入排依据:原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。
图像/No. at risk 复核:图像复核确认至少一个 KM 面板含可见 No. at risk 表。
摘要

摘要

We evaluated differences in long-term outcomes of invasive lobular carcinoma vs breast cancers of no special type treated with anthracycline-based adjuvant chemotherapy using 4 National Surgical Adjuvant Breast and Bowel Project randomized phase III trials (B-22, B-25, B-28, and B-30). Our cohort included 11 251 patients with no special type and 1231 with invasive lobular carcinoma. Patients with invasive lobular carcinoma were older, had larger and more frequently estrogen receptor-positive tumors, and more positive lymph nodes. During early follow-up (0-5 years), patients with invasive lobular carcinoma had fewer recurrences (hazard ratio [HR] = 0.797, 95% confidence interval [CI] = 0.685 to 0.929) and deaths (HR = 0.756, 95% CI = 0.623 to 0.917). After 5 years, patients with invasive lobular carcinoma had more recurrences (HR = 1.30, 95% CI = 1.085 to 1.558) and deaths (HR = 1.044, 95% CI = 0.898 to 1.214). Conditional probability analysis showed statistically significant interactions between time-period and histologic type for recurrences (P < .001) and deaths (P < .001). Patients with invasive lobular carcinoma have elevated risk of late recurrence and death compared with patients with no special type cancers.

KM 提取结果

1 个 Figure · 6 个 KM 面板

进入结果中心
KM Figure6 个面板

Figure 1

Figure 1. Plots conditioned on no more than 5 years follow-up and more than 5 years of follow-up for 4:1 matched data. Conditional event and mortality plots obtained as (1 – Kaplan–Meier estimates) × 100%. Recurrence conditional cumulative incidence plots account for competing risks (24). ILC = invasive lobular breast carcinoma; NST = no special type.

A

events

Figure 1 · Panel A

complete 待 EXE 对齐 预期 2 条 已提取 2 条

Panel A 是同一 Figure 1 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

质量提示曲线 2:frequent upward jumps
查看结果
A_2

events

Figure 1 · Panel A_2

complete 待 EXE 对齐 预期 2 条 已提取 2 条

Panel A_2 是同一 Figure 1 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

质量提示曲线 2:frequent upward jumps
查看结果
B

recurrences

Figure 1 · Panel B

complete 待 EXE 对齐 预期 2 条 已提取 2 条

Panel B 是同一 Figure 1 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

质量提示曲线 2:frequent upward jumps
查看结果
B_4

recurrences

Figure 1 · Panel B_4

complete 待 EXE 对齐 预期 2 条 已提取 2 条

Panel B_4 是同一 Figure 1 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

质量提示曲线 1:frequent upward jumps曲线 2:extreme jump曲线 2:extreme upward reversal
查看结果
C

deaths

Figure 1 · Panel C

complete 待 EXE 对齐 预期 2 条 已提取 2 条

Panel C 是同一 Figure 1 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

查看结果
C_6

deaths

Figure 1 · Panel C_6

complete 待 EXE 对齐 预期 2 条 已提取 2 条

Panel C_6 是同一 Figure 1 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

质量提示曲线 1:frequent upward jumps曲线 2:frequent upward jumps
查看结果